6ER-013 Analysis of biological treatments as possible therapeutic alternatives in refractory anti-tnf patients in crohn’s disease

BACKGROUND: At the moment the main treatment goals in Crohn’s desease (CD) are to induce and maintain remission, controlling inflammatory activity to keep the patient free of symptoms and avoid complications. PURPOSE: To establish whether vedolizumab and ustekinumab can be declared equivalent therap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Donoso-Rengifo, MC, Lopez-Santamaria, J, Murillo-Izquierdo, M, Ramos, J Cordero, Rendon-Lope, L, Alegre, E
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 6: Education and research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535249/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.506
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados